ACVC Partners

Elegen is a biotechnology company founded in 2017, focused on developing microfluidic technology to advance synthetic biology. Led by Dr. Matthew Hill, Elegen aims to revolutionize the field by engineering entire genomes and creating innovative DNA synthesizers. Their technology is designed to enhance the speed and efficiency of DNA sequence testing, thereby facilitating significant progress in biomedical research and healthcare applications. Through these efforts, Elegen seeks to contribute to the rapid development of solutions that address various challenges in the life sciences sector.

EnCharge AI specializes in developing advanced artificial intelligence hardware and software systems tailored for edge computing. The company provides a robust computing platform designed to enhance AI capabilities, enabling larger models, improved accuracy, higher resolutions, and support for multiple camera channels. By leveraging years of research and development, EnCharge AI offers differentiated technology that facilitates scalable AI architectures and flexible software integration. This allows businesses to access sophisticated AI solutions efficiently and effectively, minimizing the need for time-consuming and costly workarounds.

Helm.ai Inc. specializes in designing and developing artificial intelligence software solutions for autonomous navigation across various platforms, including self-driving cars, drones, and consumer robots. Established in 2016 and based in Redwood City, California, the company focuses on next-generation AI applications for advanced driver-assistance systems (ADAS) and fully autonomous driving. Helm.ai's technology employs an unsupervised learning approach, allowing for the training of neural networks without relying on extensive fleet data, simulation, or manual annotation. This innovative method aims to enhance the safety and scalability of autonomous technologies, and the company collaborates with global automakers on projects that are set for production. Helm.ai's offerings include full-stack real-time AI solutions, deep neural networks for both highway and urban driving, and development tools powered by its proprietary Deep Teaching™ technology.

Debut Biotechnology, Inc. is a biotechnology company based in San Diego, California, established in 2019. It specializes in biomanufacturing solutions for high-value molecules, focusing on the development of specialty enzyme solutions and continuous manufacturing processes. The company offers a range of services, including biomanufacturing cartridges, fermentation, and the immobilization of cells and enzymes. Debut Biotechnology is dedicated to creating novel immobilization techniques for enzymes, achieving high success rates and providing immobilized enzymes for continuous manufacturing systems. Its innovative approach enables the production and modification of small and large molecules, catering primarily to the pharmaceutical and specialty chemical industries. By harnessing natural enzyme technologies, Debut aims to deliver sustainable and cost-effective ingredient solutions to its clients.

Helm.ai Inc. specializes in designing and developing artificial intelligence software solutions for autonomous navigation across various platforms, including self-driving cars, drones, and consumer robots. Established in 2016 and based in Redwood City, California, the company focuses on next-generation AI applications for advanced driver-assistance systems (ADAS) and fully autonomous driving. Helm.ai's technology employs an unsupervised learning approach, allowing for the training of neural networks without relying on extensive fleet data, simulation, or manual annotation. This innovative method aims to enhance the safety and scalability of autonomous technologies, and the company collaborates with global automakers on projects that are set for production. Helm.ai's offerings include full-stack real-time AI solutions, deep neural networks for both highway and urban driving, and development tools powered by its proprietary Deep Teaching™ technology.

Boston Materials, Inc. is a manufacturer of advanced composite materials, specializing in 3D reinforced carbon fiber pre-pregs. Founded in 2016 and based in Bedford, Massachusetts, the company utilizes patented Z-axis Fiber technology, which incorporates vertically aligned carbon fibers to enhance energy transfer properties. Its product line includes Carbon Supercomposite, a magnetically assembled carbon fiber pre-preg, which finds applications across various sectors such as aerospace, automotive, marine, wind energy, and sports equipment. Boston Materials' advanced materials aim to improve thermal, electrical, and mechanical properties, offering a roll-to-roll manufacturing process with in-line quality control and an annual production capacity of one million square meters. These innovations enable industries like semiconductors and electrified vehicles to achieve greater efficiency, reliability, and weight reduction while addressing critical challenges in durability and performance.

Sepion Technologies is an advanced membrane company based in Emeryville, California, founded in 2015. The company specializes in developing a suite of highly-tunable nanoscale membranes for various industrial applications, particularly in the energy storage sector. Sepion focuses on manufacturing innovative products, including lithium-metal batteries, by integrating nanoscience, polymer chemistry, and cell engineering. Its proprietary composite membrane serves as a cost-effective alternative to traditional ceramic separators used in lithium batteries, offering improved performance and the capability to be produced in large-area formats. This innovation enables battery manufacturers to enhance energy density in their products, thereby advancing the overall efficiency of energy storage solutions.

Debut Biotechnology, Inc. is a biotechnology company based in San Diego, California, established in 2019. It specializes in biomanufacturing solutions for high-value molecules, focusing on the development of specialty enzyme solutions and continuous manufacturing processes. The company offers a range of services, including biomanufacturing cartridges, fermentation, and the immobilization of cells and enzymes. Debut Biotechnology is dedicated to creating novel immobilization techniques for enzymes, achieving high success rates and providing immobilized enzymes for continuous manufacturing systems. Its innovative approach enables the production and modification of small and large molecules, catering primarily to the pharmaceutical and specialty chemical industries. By harnessing natural enzyme technologies, Debut aims to deliver sustainable and cost-effective ingredient solutions to its clients.

Boston Materials, Inc. is a manufacturer of advanced composite materials, specializing in 3D reinforced carbon fiber pre-pregs. Founded in 2016 and based in Bedford, Massachusetts, the company utilizes patented Z-axis Fiber technology, which incorporates vertically aligned carbon fibers to enhance energy transfer properties. Its product line includes Carbon Supercomposite, a magnetically assembled carbon fiber pre-preg, which finds applications across various sectors such as aerospace, automotive, marine, wind energy, and sports equipment. Boston Materials' advanced materials aim to improve thermal, electrical, and mechanical properties, offering a roll-to-roll manufacturing process with in-line quality control and an annual production capacity of one million square meters. These innovations enable industries like semiconductors and electrified vehicles to achieve greater efficiency, reliability, and weight reduction while addressing critical challenges in durability and performance.

DarwinAI Corp. is a company that designs and develops a platform for creating deep neural networks aimed at enterprise artificial intelligence. Based in Waterloo, Canada, the company offers GenSynth, a software platform that accelerates the deep learning development cycle for developers and data scientists. GenSynth automatically generates models that meet specific performance targets while ensuring transparency and providing insights into the factors influencing decision-making. DarwinAI's technology, referred to as Generative Synthesis, optimizes and explains deep learning processes, thereby eliminating uncertainties in AI development. Additionally, the company has developed an AI-powered visual quality inspection system for the PCBA manufacturing lifecycle, which utilizes specialized optics and artificial intelligence to detect product defects. This system enhances product quality and consistency, ultimately reducing costs and improving customer satisfaction in manufacturing.

Medable, Inc. is a technology company that operates a medical-grade Platform-as-a-Service, designed to facilitate the development of compliant applications and services for the healthcare sector. The platform enables healthcare professionals, hospitals, and medical device manufacturers to create mobile and web applications that support clinical trials while adhering to health privacy regulations. Medable's offerings include solutions for telemedicine, allowing for HIPAA-compliant video consultations and capturing clinical trial outcomes remotely. The platform enhances the efficiency of clinical trials by streamlining design, recruitment, retention, and data quality, thereby improving patient access, experience, and outcomes. Founded in 2015 and headquartered in Palo Alto, California, Medable's solutions are utilized by leading biopharmaceutical companies and clinical research organizations across more than 30 countries and in 26 languages.